Verrica Pharmaceuticals (VRCA) Accumulated Depreciation & Amortization (2021 - 2025)
Historic Accumulated Depreciation & Amortization for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $1.0 million.
- Verrica Pharmaceuticals' Accumulated Depreciation & Amortization fell 1826.09% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 1826.09%. This contributed to the annual value of $1.3 million for FY2024, which is 715.5% up from last year.
- Per Verrica Pharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $1.0 million for Q3 2025, which was down 1826.09% from $1.1 million recorded in Q2 2025.
- Verrica Pharmaceuticals' Accumulated Depreciation & Amortization's 5-year high stood at $1.3 million during Q1 2025, with a 5-year trough of $113000.0 in Q3 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $802000.0, with a median of $965000.0 in 2023.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 40353.98% in 2022, then plummeted by 1826.09% in 2025.
- Verrica Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $254000.0 in 2021, then surged by 175.2% to $699000.0 in 2022, then skyrocketed by 67.95% to $1.2 million in 2023, then rose by 7.16% to $1.3 million in 2024, then fell by 17.81% to $1.0 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $1.0 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.3 million for Q1 2025.